drugset / Trial / NCT01842113

Quality of Life and Nutritional Improvements in Cirrhotic Patients

NCT01842113

Phase 4 Terminated 4 enrolled Tampa General Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether taking Rifaximin (Xifaxan) in conjunction with the use of nutritional concepts is effective in improving morbidity and quality of life in cirrhotic patients suffering from hepatic encephalopathy (HE).

Timeline

Start
2013-04
Primary completion
2014-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lactulose Other / unclassified 30 ml Oral
Comparator Rifaximin Other / unclassified 550 mg Oral